[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Alpha Galactosidase A Market Report 2017

December 2017 | 102 pages | ID: U241721B51AEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Alpha Galactosidase A market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Alpha Galactosidase A in these regions, from 2012 to 2022 (forecast).
United States Alpha Galactosidase A market competition by top manufacturers/players, with Alpha Galactosidase A sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Amicus Therapeutics, Inc.
  • Greenovation Biotech GmbH
  • iBio, Inc.
  • ISU ABXIS Co.,Ltd.
  • JCR Pharmaceuticals Co., Ltd.
  • Pharming Group N.V.
  • Protalix BioTherapeutics, Inc.
  • Shire Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Agalsidase Alfa
  • AVRRD-01
  • Migalastat Hydrochloride
  • MOSS-AGAL
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Home Care
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Alpha Galactosidase A Market Report 2017

1 ALPHA GALACTOSIDASE A OVERVIEW

1.1 Product Overview and Scope of Alpha Galactosidase A
1.2 Classification of Alpha Galactosidase A by Product Category
  1.2.1 United States Alpha Galactosidase A Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Alpha Galactosidase A Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Agalsidase Alfa
  1.2.4 AVRRD-01
  1.2.5 Migalastat Hydrochloride
  1.2.6 MOSS-AGAL
  1.2.7 Others
1.3 United States Alpha Galactosidase A Market by Application/End Users
  1.3.1 United States Alpha Galactosidase A Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Care
1.4 United States Alpha Galactosidase A Market by Region
  1.4.1 United States Alpha Galactosidase A Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Alpha Galactosidase A Status and Prospect (2012-2022)
  1.4.3 Southwest Alpha Galactosidase A Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Alpha Galactosidase A Status and Prospect (2012-2022)
  1.4.5 New England Alpha Galactosidase A Status and Prospect (2012-2022)
  1.4.6 The South Alpha Galactosidase A Status and Prospect (2012-2022)
  1.4.7 The Midwest Alpha Galactosidase A Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Alpha Galactosidase A (2012-2022)
  1.5.1 United States Alpha Galactosidase A Sales and Growth Rate (2012-2022)
  1.5.2 United States Alpha Galactosidase A Revenue and Growth Rate (2012-2022)

2 UNITED STATES ALPHA GALACTOSIDASE A MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Alpha Galactosidase A Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Alpha Galactosidase A Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Alpha Galactosidase A Average Price by Players/Suppliers (2012-2017)
2.4 United States Alpha Galactosidase A Market Competitive Situation and Trends
  2.4.1 United States Alpha Galactosidase A Market Concentration Rate
  2.4.2 United States Alpha Galactosidase A Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alpha Galactosidase A Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALPHA GALACTOSIDASE A SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Alpha Galactosidase A Sales and Market Share by Region (2012-2017)
3.2 United States Alpha Galactosidase A Revenue and Market Share by Region (2012-2017)
3.3 United States Alpha Galactosidase A Price by Region (2012-2017)

4 UNITED STATES ALPHA GALACTOSIDASE A SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Alpha Galactosidase A Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Alpha Galactosidase A Revenue and Market Share by Type (2012-2017)
4.3 United States Alpha Galactosidase A Price by Type (2012-2017)
4.4 United States Alpha Galactosidase A Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ALPHA GALACTOSIDASE A SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Alpha Galactosidase A Sales and Market Share by Application (2012-2017)
5.2 United States Alpha Galactosidase A Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALPHA GALACTOSIDASE A PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amicus Therapeutics, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alpha Galactosidase A Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amicus Therapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Greenovation Biotech GmbH
  6.2.2 Alpha Galactosidase A Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Greenovation Biotech GmbH Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 iBio, Inc.
  6.3.2 Alpha Galactosidase A Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 iBio, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 ISU ABXIS Co.,Ltd.
  6.4.2 Alpha Galactosidase A Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 JCR Pharmaceuticals Co., Ltd.
  6.5.2 Alpha Galactosidase A Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pharming Group N.V.
  6.6.2 Alpha Galactosidase A Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pharming Group N.V. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Protalix BioTherapeutics, Inc.
  6.7.2 Alpha Galactosidase A Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shire Plc
  6.8.2 Alpha Galactosidase A Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shire Plc Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ALPHA GALACTOSIDASE A MANUFACTURING COST ANALYSIS

7.1 Alpha Galactosidase A Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alpha Galactosidase A

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alpha Galactosidase A Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alpha Galactosidase A Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALPHA GALACTOSIDASE A MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Alpha Galactosidase A Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Alpha Galactosidase A Sales Volume Forecast by Type (2017-2022)
11.3 United States Alpha Galactosidase A Sales Volume Forecast by Application (2017-2022)
11.4 United States Alpha Galactosidase A Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Alpha Galactosidase A
Figure United States Alpha Galactosidase A Market Size (K Pcs) by Type (2012-2022)
Figure United States Alpha Galactosidase A Sales Volume Market Share by Type (Product Category) in 2016
Figure Agalsidase Alfa Product Picture
Figure AVRRD-01 Product Picture
Figure Migalastat Hydrochloride Product Picture
Figure MOSS-AGAL Product Picture
Figure Others Product Picture
Figure United States Alpha Galactosidase A Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Alpha Galactosidase A by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure United States Alpha Galactosidase A Market Size (Million USD) by Region (2012-2022)
Figure The West Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alpha Galactosidase A Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Alpha Galactosidase A Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Alpha Galactosidase A Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alpha Galactosidase A Sales Share by Players/Suppliers
Figure 2017 United States Alpha Galactosidase A Sales Share by Players/Suppliers
Figure United States Alpha Galactosidase A Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Alpha Galactosidase A Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Alpha Galactosidase A Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alpha Galactosidase A Revenue Share by Players/Suppliers
Figure 2017 United States Alpha Galactosidase A Revenue Share by Players/Suppliers
Table United States Market Alpha Galactosidase A Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Alpha Galactosidase A Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Alpha Galactosidase A Market Share of Top 3 Players/Suppliers
Figure United States Alpha Galactosidase A Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alpha Galactosidase A Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alpha Galactosidase A Product Category
Table United States Alpha Galactosidase A Sales (K Pcs) by Region (2012-2017)
Table United States Alpha Galactosidase A Sales Share by Region (2012-2017)
Figure United States Alpha Galactosidase A Sales Share by Region (2012-2017)
Figure United States Alpha Galactosidase A Sales Market Share by Region in 2016
Table United States Alpha Galactosidase A Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Alpha Galactosidase A Revenue Share by Region (2012-2017)
Figure United States Alpha Galactosidase A Revenue Market Share by Region (2012-2017)
Figure United States Alpha Galactosidase A Revenue Market Share by Region in 2016
Table United States Alpha Galactosidase A Price (USD/Pcs) by Region (2012-2017)
Table United States Alpha Galactosidase A Sales (K Pcs) by Type (2012-2017)
Table United States Alpha Galactosidase A Sales Share by Type (2012-2017)
Figure United States Alpha Galactosidase A Sales Share by Type (2012-2017)
Figure United States Alpha Galactosidase A Sales Market Share by Type in 2016
Table United States Alpha Galactosidase A Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Alpha Galactosidase A Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alpha Galactosidase A by Type (2012-2017)
Figure Revenue Market Share of Alpha Galactosidase A by Type in 2016
Table United States Alpha Galactosidase A Price (USD/Pcs) by Types (2012-2017)
Figure United States Alpha Galactosidase A Sales Growth Rate by Type (2012-2017)
Table United States Alpha Galactosidase A Sales (K Pcs) by Application (2012-2017)
Table United States Alpha Galactosidase A Sales Market Share by Application (2012-2017)
Figure United States Alpha Galactosidase A Sales Market Share by Application (2012-2017)
Figure United States Alpha Galactosidase A Sales Market Share by Application in 2016
Table United States Alpha Galactosidase A Sales Growth Rate by Application (2012-2017)
Figure United States Alpha Galactosidase A Sales Growth Rate by Application (2012-2017)
Table Amicus Therapeutics, Inc. Basic Information List
Table Amicus Therapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table Greenovation Biotech GmbH Basic Information List
Table Greenovation Biotech GmbH Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table iBio, Inc. Basic Information List
Table iBio, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table ISU ABXIS Co.,Ltd. Basic Information List
Table ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table JCR Pharmaceuticals Co., Ltd. Basic Information List
Table JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table Pharming Group N.V. Basic Information List
Table Pharming Group N.V. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table Protalix BioTherapeutics, Inc. Basic Information List
Table Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table Shire Plc Basic Information List
Table Shire Plc Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Plc Alpha Galactosidase A Sales Growth Rate (2012-2017)
Figure Shire Plc Alpha Galactosidase A Sales Market Share in United States (2012-2017)
Figure Shire Plc Alpha Galactosidase A Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha Galactosidase A
Figure Manufacturing Process Analysis of Alpha Galactosidase A
Figure Alpha Galactosidase A Industrial Chain Analysis
Table Raw Materials Sources of Alpha Galactosidase A Major Players/Suppliers in 2016
Table Major Buyers of Alpha Galactosidase A
Table Distributors/Traders List
Figure United States Alpha Galactosidase A Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Alpha Galactosidase A Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Alpha Galactosidase A Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Alpha Galactosidase A Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Alpha Galactosidase A Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alpha Galactosidase A Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications